Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Visa
V
|
+$55.5M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$35.4M |
| 3 |
International Paper
IP
|
+$25.3M |
| 4 |
DoorDash
DASH
|
+$21.9M |
| 5 |
Natera
NTRA
|
+$17.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$120M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$24.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 11.72% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Ramaco Resources Class A
METC
$1.71B
| $462K | ﹤0.01% |
56,618
-792
| -1% | -$6.46K |
|
2352
Allegiant Air
ALGT
$1.14B
| $461K | ﹤0.01% |
8,928
-200
| -2% | -$10.3K |
|
2353
SIGA Technologies
SIGA
$649M
| $460K | ﹤0.01% |
83,900
| – | – |
|
2354
Phathom Pharmaceuticals
PHAT
$797M
| $460K | ﹤0.01% |
73,300
| – | – |
|
2355
Erasca
ERAS
$479M
| $450K | ﹤0.01% |
328,700
-32,500
| -9% | -$44.5K |
|
2356
Stoke Therapeutics
STOK
$1.28B
| $448K | ﹤0.01% |
67,300
| – | – |
|
2357
TaskUs
TASK
$1.57B
| $446K | ﹤0.01% |
32,700
| – | – |
|
2358
Target Hospitality
TH
$862M
| $442K | ﹤0.01% |
67,100
-3,000
| -4% | -$19.7K |
|
2359
ChargePoint
CHPT
$245M
| $441K | ﹤0.01% |
36,425
-3,895
| -10% | -$47.1K |
|
2360
Bristow Group
VTOL
$1.09B
| $439K | ﹤0.01% |
13,900
| – | – |
|
2361
Savers
SVV
$1.99B
| $436K | ﹤0.01% |
63,200
| – | – |
|
2362
Redwire
RDW
$1.29B
| $428K | ﹤0.01% |
+51,600
| New | +$428K |
|
2363
Centuri Holdings
CTRI
$2.04B
| $421K | ﹤0.01% |
25,700
-8,900
| -26% | -$146K |
|
|
LUCK
2364
Lucky Strike Entertainment Corporation
LUCK
$1.37B
| $418K | ﹤0.01% |
42,800
-10,100
| -19% | -$98.6K |
|
2365
Ironwood Pharmaceuticals
IRWD
$213M
| $416K | ﹤0.01% |
282,700
| – | – |
|
2366
Pharvaris
PHVS
$1.51B
| $412K | ﹤0.01% |
26,257
| – | – |
|
2367
Universal Logistics Holdings
ULH
$654M
| $409K | ﹤0.01% |
15,600
| – | – |
|
2368
Soho House & Co
SHCO
$1.73B
| $409K | ﹤0.01% |
66,200
-4,400
| -6% | -$27.2K |
|
2369
Humacyte
HUMA
$243M
| $406K | ﹤0.01% |
237,900
+65,800
| +38% | +$112K |
|
2370
ARKO Corp
ARKO
$576M
| $405K | ﹤0.01% |
102,461
| – | – |
|
2371
Digimarc
DMRC
$214M
| $401K | ﹤0.01% |
31,300
| – | – |
|
2372
Sana Biotechnology
SANA
$821M
| $400K | ﹤0.01% |
237,900
| – | – |
|
2373
Eve Holding
EVEX
$1.13B
| $383K | ﹤0.01% |
+115,400
| New | +$383K |
|
2374
Pulse Biosciences
PLSE
$1.1B
| $383K | ﹤0.01% |
23,800
-12,100
| -34% | -$195K |
|
2375
Oric Pharmaceuticals
ORIC
$1.06B
| $382K | ﹤0.01% |
68,400
+6,000
| +10% | +$33.5K |
|